Does intravenous (IV) iron supplements cause melena in patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Does IV Iron Cause Melena-Appearing Stool?

No, intravenous (IV) iron does not cause melena or melanotic-appearing stool because it bypasses the gastrointestinal tract entirely and is delivered directly into the bloodstream.

Why IV Iron Does Not Cause Dark Stool

  • IV iron formulations are administered directly into the venous system and are taken up by the reticuloendothelial system for incorporation into hemoglobin or storage as ferritin 1
  • Unlike oral iron supplements, IV iron does not pass through the gastrointestinal tract, so there is no unabsorbed iron reaching the colon to darken the stool 2
  • The mechanism by which oral iron causes black stool—unabsorbed iron passing into the colon—simply does not occur with IV administration 2

Contrast with Oral Iron Supplements

  • Oral iron supplements commonly cause stool to turn dark or black as a benign side effect, resulting from the majority of unabsorbed iron reaching the colon 2
  • Only a small percentage of oral iron is absorbed in the small intestine, with most passing unabsorbed into the colon where it causes the characteristic black discoloration 2
  • This is why oral iron supplementation is associated with high rates of gastrointestinal adverse effects including nausea, flatulence, and diarrhea, problems that are avoided with IV iron products 1

Clinical Implications

  • If a patient on IV iron develops melena or black tarry stools, this represents true gastrointestinal bleeding and requires urgent evaluation 3, 4
  • Hemodialysis patients receiving IV iron are particularly prone to occult GI bleeding from uremic enteropathy, uremic platelet dysfunction, and anticoagulation, with fecal blood loss quantified at 6.27 mL/day (2.2 L/year) 1
  • Do not dismiss melanotic stools in patients receiving IV iron as a benign medication effect—investigate for pathological bleeding sources 3, 4

Important Caveat

  • Gastric siderosis from oral ferrous sulfate can cause melena through mucosal injury, but this is specifically related to oral iron deposition in gastric mucosa, not IV administration 5
  • The case reports of melena in patients receiving IV iron supplementation describe actual GI bleeding from underlying pathology (such as vascular malformations), not a medication effect 3, 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Iron Deficiency Anemia Treatment in Adults

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

An unusual cause of gastrointestinal bleeding in a hemodialysis patient.

Hemodialysis international. International Symposium on Home Hemodialysis, 2018

Research

Blue rubber bleb nevus syndrome.

The American journal of gastroenterology, 1996

Related Questions

What is the management for melena caused by iron fumarate?
What is the next step in management for a 50-year-old man with melena and normal upper GI endoscopy and colonoscopy results?
What is the management plan for an 89-year-old patient with a gastrointestinal (GI) bleed on Eliquis (apixaban) for paroxysmal atrial fibrillation (A Fib) with possible iron deficiency anemia as a cause of bleeding?
What is the management of melena in patients with Chronic Kidney Disease (CKD) on hemodialysis?
What is the significance of a past episode of melena (black, tarry stools), which occurred 4 years ago, with subsequent normal colonoscopy (examination of the colon) and endoscopy (examination of the upper gastrointestinal tract), and no recurrence of melena since?
What are the guidelines for managing biological risk and preventing tuberculosis (TB) transmission in high-risk occupational settings, such as healthcare and mining, including preventive measures, screening, and treatment protocols for workers?
Is intramuscular (IM) ceftriaxone (a third-generation cephalosporin) a suitable treatment option for a patient with a urinary tract infection (UTI) that is resistant to ciprofloxacin (a fluoroquinolone antibiotic)?
Do asymptomatic patients with enteroaggregative E. coli (EAEC) and enteropathogenic E. coli (EPEC) in their stool require treatment, particularly those with compromised immune systems or a history of severe gastrointestinal illness?
What is the best treatment for a yeast-based diaper rash in an infant?
What are the appropriate abortive medications for an 11-year-old patient with headaches and no significant past medical history?
What is the recommended treatment approach for hypertension (HTN) with hydralazine in a general adult population without severe comorbidities?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.